Literature DB >> 20107938

Association between the -402GA, -401GT, and -323ins10-bp polymorphisms of factor VII gene and breast cancer.

Aydan Eroğlu1, Ayşenur Oztürk, Nejat Akar.   

Abstract

BACKGROUND AND
PURPOSE: Recent data have shown that the hemostatic system may play a role in cancer development and progression. To test whether factor VII (FVII) can be a candidate factor for breast cancer, we have evaluated the distribution of FVII gene polymorphisms in breast cancer patients and healthy subjects.
METHODS: The nested case-control study consisted of 92 women with breast cancer (group 1) and 80 control subjects (in age-matched women) (group 2). Genotyping of the -323ins10-bp, -401GT, and -402GA polymorphisms of the FVII gene was performed by the method of single-strand conformation polymorphism analysis and sequencing.
RESULTS: A significant difference was observed in the distribution of the -402GA genotype and allele frequencies in breast cancer and control cases (p < 0.05). For other polymorphisms of the FVII gene, the distributions of genotypes and allele frequencies were not significantly different between two groups (p > 0.05). There was also a significant difference between the distributions of the haplotypes in breast cancer patients and control subjects (p < 0.05).
CONCLUSION: Although the number of cases in this study was small, the preliminary findings revealed a possible contribution of the FVII -402GA polymorphism in the development of breast cancer. However, further case-control studies with larger series are needed to confirm our findings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107938     DOI: 10.1007/s12282-009-0189-6

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  3 in total

1.  Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII.

Authors:  E Yildirim; K Erol; A Birdane
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

2.  Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.

Authors:  Mari Tinholt; Marte Kathrine Viken; Anders Erik Dahm; Hans Kristian Moen Vollan; Kristine Kleivi Sahlberg; Oystein Garred; Anne-Lise Børresen-Dale; Anne Flem Jacobsen; Vessela Kristensen; Ida Bukholm; Rolf Kåresen; Ellen Schlichting; Grethe Skretting; Benedicte Alexandra Lie; Per Morten Sandset; Nina Iversen
Journal:  BMC Cancer       Date:  2014-11-19       Impact factor: 4.430

3.  Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases.

Authors:  Chih-Che Lin; Chun-Hsien Wu; Li-Yu Chen; Ming-Chao Tsai; Ahmed M Elsarawy; Kuang-Tzu Huang
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.